Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

Study ID
NCT00374660

Study type
Interventional

Study phase
Phase 1/Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

The purpose of this study is to determine the maximum tolerated dose (MTD) and to investigate the efficacy, safety and pharmacokinetics of irofulven combined with oxaliplatin in patients with advanced solid tumors.

More informations

Trial Starting Date

Jun 30,2003

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

In order to facilitate the use of our website, we use cookies.